Accordingly, our findings revealed that strain USE measurement of parathyroid lesions, as well as serum Ca and PTH levels, some B-mode US features (diameter, volume, hypoechogenicity and cystic component) and MIBI positivity, may help differentiate between APAs, PAs and parathyroid hyperplasia lesions. This evidence concerns the gene PTH and parathyroid hyperplasia.